Revolutionizing Cancer Detection: LifeCell Diagnostics Unveils Innovative Onco Packages for Early Diagnosis in India
New Delhi, Dec 02: Cancer is fast emerging as one of India’s biggest health challenges, with an estimated 1.5 million new cases expected in 2025. Alarming statistics reveal that 1 in 9 Indians is likely to face cancer during their lifetime. The real concern? Only about 29% of cancers are detected early, making treatment more challenging and less effective.
Recognising this urgent need, LifeCell Diagnostics is transforming cancer care through its advanced Onco Packages, which enable early detection of cancer risks and enhance treatment outcomes with precision diagnostics.
“ Detecting cancer early isn’t just about saving lives; it’s also about improving quality of life and treatment outcomes. Through advanced genetic testing, LifeCell Diagnostics is making precision oncology accessible and affordable across India,” said Dr Tina Bhardwaj, Head- Oncogenomics, LifeCell Diagnostics.
Early Detection: The Game Changer
Early detection remains one of the most effective weapons against cancer. It significantly improves survival rates while reducing treatment costs and complexities. LifeCell’s Onco Packages leverage cutting-edge technologies, including genetic testing and liquid biopsy panels.
For example, the Hereditary Cancer Gene Panel (ONCO) analyses 106 clinically significant genes through a simple blood test, detecting genetic predispositions to breast, ovarian, colorectal, prostate, and pancreatic cancers. This empowers individuals to take informed actions for preventive care and lifestyle modification.
Making Advanced Cancer Testing Accessible Across India
Another major barrier to detecting cancer on time in India has been geographic and economic disparity. Here again, LifeCell Diagnostics bridges this gap with its nationwide sample collection network. They have 30+ labs that offer home-collection services even in remote locations. By decentralising access to advanced cancer screening, LifeCell diagnostics is ensuring that cutting-edge cancer testing is no longer confined to metro cities, bridging the gap between urban and rural healthcare.
What Makes the Onco Packages Different?
LifeCell Diagnostics is redefining accessibility to genetic testing by integrating advanced technologies like the NovaSeq 6000 platform, enabling rapid, high-throughput genetic analysis with exceptional precision.
These advanced technologies come along with several benefits, like
Comprehensive Genetic Coverage
Beyond the traditional gene panels, the Onco Packages are designed to assess a wide spectrum of inherited-risk genes. By identifying clinically significant variants linked to breast, ovarian, colorectal and prostate cancers, these tests give individuals actionable insights for targeted screening, personalised risk management and early intervention.
Actionable Insights
Identifies potential cancer risks early, allowing individuals to adopt preventive measures or opt for proactive interventions for better outcomes.
Precision-Based Outcomes
Enables personalised monitoring and less aggressive, more effective treatment options. And there is no lie in telling that affordable testing can definitely change the way India deals with cancer.
Nationwide Reach
With robust logistics and phlebotomy network, LifeCell Diagnostics makes advanced cancer testing accessible and affordable to individuals across every corner of India.
Transforming the Future of Cancer Care
LifeCell Diagnostics’ Onco Packages mark a significant milestone in India’s journey toward building a preventive healthcare ecosystem. By combining advanced technology with nationwide accessibility, LifeCell Diagnostics is shifting the focus from reactive treatment after diagnosis to early detection, timely intervention, and long-term disease prevention.
As awareness grows and access expands, early detection will no longer be a privilege. It will become a standard part of healthcare for every Indian. Through its science-backed approach, LifeCell Diagnostics is empowering individuals to take control of their health and giving families hope for a future where cancer is caught early, managed better, and feared less.
